Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.

TitleApc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.
Publication TypeJournal Article
Year of Publication1997
AuthorsMahmoud NN, Boolbol SK, Bilinski RT, Martucci C, Chadburn A, Bertagnolli MM
JournalCancer Res
Volume57
Issue22
Pagination5045-50
Date Published1997 Nov 15
ISSN0008-5472
KeywordsAnalysis of Variance, Animals, Anti-Inflammatory Agents, Non-Steroidal, Apoptosis, beta Catenin, Cell Division, Cell Movement, Cytoskeletal Proteins, Female, Genes, APC, Intestinal Mucosa, Intestine, Small, Mice, Mice, Inbred C57BL, Proliferating Cell Nuclear Antigen, Sulindac, Trans-Activators
Abstract

Apc-associated intestinal tumor formation appears to require functional loss of both Apc alleles. Apc has, therefore, been classified as a tumor suppressor gene. Loss of APC protein function results in increased intracellular beta-catenin, a molecule important to both cell-cell adhesion and regulation of cellular growth. In mice bearing a germ-line Apc mutation, we found that enterocyte beta-catenin expression was also increased in histologically normal intestinal mucosa. Enterocyte crypt-villus migration was decreased by 25%, and treatment of Min/+ animals with sulindac sulfide normalized both beta-catenin expression and enterocyte migration. Our data suggest that alterations in enterocyte migration occur in cells bearing a single mutant Apc allele, and that sulindac sulfide may normalize enterocyte growth in these cells.

Alternate JournalCancer Res
PubMed ID9371501
Grant List525435 / / PHS HHS / United States
NCI-1R29CA74162-01 / CA / NCI NIH HHS / United States
Related Faculty: 
Amy Chadburn, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700